Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Abroad (travel likely)Active Not RecruitingPHASE2

Conditions

Uveal Melanoma · Ocular Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Moffitt Cancer Center, Tampa, Florida, United States

Study leads

Nikhil I Khushalani, MD
Principal Investigator
Moffitt Cancer Center

View source on ClinicalTrials.gov

No study contact email or phone is listed for this trial.

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tampa, United States

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Melanoma · Clear-Cell Renal-Cell Carcinoma (ccRCC) · Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · San Francisco, United States

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma · Uveal Melanoma, Metastatic · Uveal Melanoma, Recurrent

Abroad (travel likely)RecruitingPHASE1, PHASE2

Scottsdale, United States · Denver, United States

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

Melanoma · Melanoma, Uveal · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rotterdam, Netherlands